Avantor Releases 2024 Science for Goodness Sustainability Report
June 19, 2024 at 01:57 pm
Share
RADNOR - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today.
The report highlights the meaningful progress Avantor made in 2023 against four Science for Goodness sustainability pillars: People & Culture, Innovation & Environment, Community Engagement, and Governance & Integrity.
'Our Science for Goodness platform is integral to our business strategy and to the value that we provide to our stakeholders,' said Michael Stubblefield, President and CEO of Avantor. 'We are pleased with the progress we have made and remain committed to creating a better, healthier world.'
Highlights from Avantor's 2024 Sustainability Report include: People & Culture: Avantor earned a top score on the Human Rights Campaign's 2023 Corporate Equality Index, a national benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. As part of our efforts to promote inclusion and respect in the workplace, one-quarter of associates participated in Associate-Centric Teams (ACTs) which provide our associates with opportunities to elevate their voices and deepen their understanding of others' experiences and perspectives.
Innovation & Environment: Avantor achieved its 2025 emissions reduction target two years ahead of schedule, reducing operational greenhouse gas emissions by 16.7 percent from 2019 to 2023. Having achieved this critical milestone, we have now set new targets for 2030 to reduce Scope 1 and 2 emissions by 50 percent from a 2020 baseline and reduce Scope 3 emissions by 25 percent from a 2020 baseline.
Community Engagement: In 2023, the Avantor Foundation awarded more than $1.2 million in grants to provide healthcare services and STEM education opportunities to underserved communities where Avantor has a presence. We also empowered our associates to support organizations worldwide that bring our mission to life, and in 2023, they contributed nearly 10,000 volunteer hours.
Governance & Integrity: Avantor launched our Responsible Supplier Program in 2023, aiming to improve supplier performance across four priority areas: climate change, human rights, resource circularity and nature conservation. Building on our strong supplier relationships, some of which have been in place for more than 20 years, Avantor enrolled more than 340 suppliers, representing 45 percent of our supplier spend, into the program in 2023.
About Avantor
Avantor is a leading life science tools company and global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. From discovery to delivery, we work side-by-side with scientists around the world to enable breakthroughs in medicine, healthcare, and technology at scale. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
AVANTOR, INC. 
